Inventor
SOLOMON DANIEL M
US26 patents
⚠️ This page may combine multiple inventors who share the name “SOLOMON DANIEL M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
24 patentsUS7220735B2May 22, 2007
Benzimidazolone histamine H3 antagonists
SCHERING CORP31 citations92
US7105505B2Sep 12, 2006
Benzimidazole derivatives useful as histamine H3 antagonists
SCHERING CORP27 citations92
US6849621B2Feb 1, 2005
Piperidine compounds
SCHERING CORP39 citations92
US6100279AAug 8, 2000
Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom
SCHERING CORP53 citations92
US5538986AJul 23, 1996
Tricyclic derivatives, compositions and methods of use
SCHERING CORP23 citations91
US7638531B2Dec 29, 2009
Phenoxypiperidines and analogs thereof useful as histamine H3 antagonists
SCHERING CORP19 citations83
US4140780AFeb 20, 1979
Pharmaceutical compositions comprising N-diphenylalkyl-2-benzyl azacyclic compounds and methods for their use
SCHERING CORP7 citations74
US4052383AOct 4, 1977
N-diphenylalkyl-2-benzyl azacyclic compounds
SCHERING CORP11 citations74
US5464840ANov 7, 1995
Tricyclic derivatives, compositions and methods of use
SCHERING CORP10 citations73
US5939431AAug 17, 1999
Naphthyridines which affect IL-4 and G-CSF
SCHERING CORP12 citations72
US6211182B1Apr 3, 2001
Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms
SCHERING CORP3 citations63
US4196124AApr 1, 1980
1-Benzhydryl-2-benzimidoyl-azetidine
SCHERING CORP2 citations63
US4183923AJan 15, 1980
Antipsoriatic compositions
SCHERING CORP3 citations63
US7879880B2Feb 1, 2011
Substituted aniline derivatives useful as histamine H3 antagonists
SCHERING CORP5 citations62
US7635705B2Dec 22, 2009
Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
SCHERING CORP2 citations62
US4816458AMar 28, 1989
Method of treating hyperploliferative skin disease with substituted-2,3-dihydro-6-substituted -pyrimido[2,1]-purine-4,8(1H,9H)diones
SCHERING CORP3 citations62
US5767120AJun 16, 1998
Tricyclic derivatives, compositions and methods of use
SCHERING CORP3 citations60
US5688805ANov 18, 1997
Tricyclic derivatives, compositions and methods of use
SCHERING CORP3 citations60
US4847377AJul 11, 1989
Substituted-2,3-dihydro-6-substituted-pyrimido[2,1-F]-purine-4,8(1H,9H)-diones
SCHERING CORP3 citations59
US4666914AMay 19, 1987
Anti-inflammatory and anti-allergic substituted-2,3-dihydro-6-(hydroxy)pyrimido[2,1-f]-purine-4,8(1H,9H)-diones
SCHERING CORP2 citations59
US6506756B2Jan 14, 2003
Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
SCHERING CORP1 citations52
US4173566ANov 6, 1979
1-Benzhydryl-2-cyanoazetidine
SCHERING CORP1 citations52
US7238688B2Jul 3, 2007
Piperidine compounds
SCHERING CORP1 citations51
US6762186B2Jul 13, 2004
Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists
SCHERING CORP1 citations46